Almac Co. Ltd. (354320)
KRX SM KRX SM Primary Summary
Almac Co. Ltd. (354320) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Almac Co. Ltd. ever had a stock split?
Almac Co. Ltd. Profile
| Diversified Consumer Services Industry | Consumer Discretionary Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Almac Co. Ltd. is a key player within the healthcare and pharmaceutical landscape, specializing in facilitating the journey of drugs from the conceptual phases to being readily available in the market. The enterprise prides itself on its innovative approaches to streamline the intricate processes associated with drug development. With its roots deeply embedded in research, development, and manufacturing, Almac Co. Ltd. exerts a significant influence on both the biotechnology and pharmaceutical industries. It stands out for its comprehensive offering of services, ensuring that therapeutic solutions are developed efficiently and reach global markets swiftly. Headquarters located in Craigavon, Northern Ireland, Almac Co. Ltd. has established a global network that underlines its commitment to accelerating drug development cycles, ensuring adherence to regulatory guidelines across different regions, and working towards making healthcare more cost-effective and medications more accessible worldwide.
Products and Services
- Clinical Trial Management
- Bioscience Research
- Global Drug Supply Management
- Specialized Analytics
This service provides end-to-end management of clinical trials, encompassing everything from trial design and patient recruitment to data analysis and reporting. Almac's expertise in this area ensures that trials are conducted efficiently, adhere to regulatory standards, and yield valuable data for advancing medical science.
Almac is at the forefront of bioscience research, offering a wide range of services aimed at understanding the biological mechanisms underlying diseases. This research is crucial for the discovery and development of new therapeutic methods and drugs, leveraging cutting-edge technologies and methodologies.
This service ensures the secure and effective distribution of medications worldwide, managing every aspect from production to delivery. Almac's global drug supply management capabilities are critical for meeting the demand for pharmaceuticals across different countries, mitigating supply chain risks, and ensuring that patients receive their treatments on time.
Almac offers specialized analytics services, including the analysis of clinical trial data, drug efficacy and safety assessments, and market analysis. These services provide invaluable insights that inform decision-making processes in drug development and commercialization, ensuring that only the most effective and safe drugs reach the market.
